Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentamidine isethionate 3-day versus 7-day regimen for cutaneous leishmaniasis in Suriname
NL-OMON23868Recruiting
- Sponsor
- Royal Tropical Institute
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pentamidine in cutaneous leishmaniasis (CL) (2 arms), sponsored by Royal Tropical Institute. Primary endpoints: Clinical relapse / treatment success and Parasitological cure rate. Started Jan 2009; status: recruiting.
02
Drugs
pentamidine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NL-OMON23868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23868.